Clinical Investigation Evaluating the Use of NETSmart Solution , Incorporated to NETSoins Software, in the Care and Support of Elderly People Living in Nursing Homes (NETSMART DM)

Teranga Software

Status: Terminated

Conditions: Undernutrition; Pressure Injury; Drug Interaction; Fall Prevention

Treatments: Device: NETSmart software

Study type: Interventional

Funder types: Industry

Identifiers

NCT07027358

2024-A00812-45

Details and patient eligibility

About

NETSmart software is designed to help doctors, nurses and care assistants adapt the care of elderly people living in nursing homes to the following risks:

• pressure injuries
• undernutrition
• interactions between different drugs
• falls. The software analyzes the information in your medical records, alerts your medical team to any points of vigilance, and suggests appropriate recommendations.

The study comprises 2 distinct phases:

• An initial 4-month phase, during which the medical staff will simply assess whether the NETSmart software's recommendations are relevant, without changing their current practice, i.e. they will continue to care for you as usual;
• A second 6-month phase, during which your caregivers will follow the software's recommendations if they feel they are relevant, and potentially adapt your care.

Enrollment: 30 patients

Sex: All

Ages: 70+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male or female, at least 70 years old
• Permanent resident at an investigation site for at least 6 months.
• Considered an at-risk patient, i.e. meeting at least one of the following criteria :
• Braden score < 16
• At risk of pressure ulcer according to the investigator's judgment
• At risk of undernutrition as judged by the investigator
• Undergoing at least 6 drug treatments
• At risk of falls as judged by the investigator
• Affiliated with the French social security system
• Having given informed, dated and signed consent to participate in the investigation

Exclusion criteria

• Patient with a life expectancy of less than 2 months as judged by the investigator
• Patient who is participating or has participated in another investigation or study involving the use of a medical device or drug within 30 days prior to inclusion

Trial design

Primary purpose: Prevention

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

30 participants in 1 patient group

NETSmart

Experimental group

Description:

Use of NETSmart software by healthcare professionals for these patients

Treatment:

Device: NETSmart software